Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Mapping
Background and Rationale
Spatial propagation mapping study to define alpha-synuclein spreading patterns in dementia with Lewy bodies (DLB), testing whether cortical-first spreading distinguishes DLB from Parkinson's disease dementia (PDD) where spreading is brainstem-first.
Protocol: Post-mortem brain mapping in 40 DLB cases and 40 PDD cases across 20 brain regions (Braak staging + cortical and limbic sampling). Methods: (1) Alpha-synuclein phospho-Ser129 immunohistochemistry with stereological quantification. (2) Seeding amplification assay (SAA/RT-QuIC) measuring alpha-synuclein seeding activity per region. (3) Cryo-EM of filaments from early-affected regions to characterize DLB vs. PDD strain differences. (4) Synaptic alpha-synuclein localization via super-resolution microscopy (STED). (5) Correlation with clinical records (onset of cognitive vs. motor symptoms, dream enactment behavior, visual hallucination timing).
...Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Mapping
Background and Rationale
Spatial propagation mapping study to define alpha-synuclein spreading patterns in dementia with Lewy bodies (DLB), testing whether cortical-first spreading distinguishes DLB from Parkinson's disease dementia (PDD) where spreading is brainstem-first.
Protocol: Post-mortem brain mapping in 40 DLB cases and 40 PDD cases across 20 brain regions (Braak staging + cortical and limbic sampling). Methods: (1) Alpha-synuclein phospho-Ser129 immunohistochemistry with stereological quantification. (2) Seeding amplification assay (SAA/RT-QuIC) measuring alpha-synuclein seeding activity per region. (3) Cryo-EM of filaments from early-affected regions to characterize DLB vs. PDD strain differences. (4) Synaptic alpha-synuclein localization via super-resolution microscopy (STED). (5) Correlation with clinical records (onset of cognitive vs. motor symptoms, dream enactment behavior, visual hallucination timing).
Primary Outcome: Regional seeding activity map distinguishing DLB from PDD spreading patterns. Success Criteria: Identification of >3 brain regions with significantly different seeding activity profiles between DLB and PDD (p<0.01), supporting distinct propagation routes. Model System: Human post-mortem tissue with clinical correlation. Expected Timeline: 24 months. Estimated Cost: $800K.
This experiment directly tests predictions arising from the following hypotheses:
- Microbial Metabolite-Mediated α-Synuclein Disaggregation
- Cross-Seeding Prevention Strategy
- Enteric Nervous System Prion-Like Propagation Blockade
- Gut Barrier Permeability-α-Synuclein Axis Modulation
- Noradrenergic-Tau Propagation Blockade
Experimental Protocol
Phase 1: Cell Line Preparation and Alpha-Synuclein Introduction (Days 1-3)• Maintain H4 human neuroglioma cells and differentiated SH-SY5Y neuroblastoma cells at 37°C, 5% CO2
• Seed cells in 96-well imaging plates at 5×10^4 cells/well for time-course analysis
• Prepare recombinant alpha-synuclein preformed fibrils (PFFs) at 5 μg/mL concentration
• Introduce fluorescently-labeled alpha-synuclein (Alexa Fluor 488) to donor cells via lipofection
• Establish co-culture system with 1:1 ratio of donor (alpha-synuclein+) to recipient cells
Phase 2: Spatial Propagation Monitoring (Days 4-21)
• Perform live-cell confocal microscopy every 48 hours using 63x oil immersion objective
• Track alpha-synuclein aggregation using ThioflavinS staining (1 μg/mL, 30 min incubation)
• Measure cell-to-cell transfer using proximity ligation assay (PLA) for alpha-synuclein interactions
• Quantify spreading distance using automated image analysis (minimum 200 cells per timepoint)
• Apply sequential staging criteria based on Braak staging adapted for cell culture models
Phase 3: Molecular Validation and Staging Classification (Days 22-25)
• Fix cells at defined timepoints (6h, 24h, 72h, 7d, 14d, 21d) using 4% paraformaldehyde
• Perform immunocytochemistry using phospho-alpha-synuclein (Ser129) primary antibody (1:1000)
• Conduct Western blot analysis for alpha-synuclein oligomers and fibrils
• Apply machine learning-based staging algorithm to classify propagation patterns
• Validate results using transmission electron microscopy for fibril morphology
Expected Outcomes
Progressive Alpha-Synuclein Spreading: Observe 15-25% increase in alpha-synuclein positive cells per 48-hour interval, reaching 60-80% coverage by day 21
Staged Propagation Pattern: Identify distinct staging phases with Stage I (0-72h) showing local seeding, Stage II (3-7d) demonstrating short-range spreading, and Stage III (7-21d) exhibiting long-range propagation
Distance-Dependent Transfer: Measure exponential decay in transfer efficiency with distance, showing 80% efficiency within 50μm, 40% at 100μm, and <10% beyond 200μm
Phosphorylation Dynamics: Detect 3-5 fold increase in phospho-alpha-synuclein (Ser129) levels in recipient cells within 24-48 hours of contact
Temporal Aggregation Kinetics: Observe sigmoidal aggregation curve with lag phase (0-48h), exponential growth phase (48-168h), and plateau phase (>168h)
Morphological Validation: Confirm presence of 8-12 nm diameter alpha-synuclein fibrils in recipient cells using electron microscopy by day 14Success Criteria
•
Statistical Significance: Achieve p<0.01 for cell-to-cell transfer efficiency compared to control conditions using two-way ANOVA with Bonferroni correction
•
Staging Validation: Successfully classify ≥85% of observed propagation patterns into defined stages using automated scoring algorithm with inter-rater reliability κ>0.8
•
Quantitative Spreading: Demonstrate measurable spatial gradient with correlation coefficient r>0.7 between distance and transfer probability
•
Molecular Confirmation: Achieve >3-fold enrichment of phospho-alpha-synuclein in recipient cells with Western blot band intensity analysis (n≥6 biological replicates)
•
Temporal Reproducibility: Maintain <15% coefficient of variation in propagation kinetics across independent experimental runs (minimum n=4)
•
Model Validation: Confirm fibril morphology matches in vivo DLB characteristics with >90% agreement between electron microscopy observers